ArriVent BioPharma, Inc. Common Stock (AVBP) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
010M20M30M40M50M60M70M80MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EBITDA

EBITDA
-80M-70M-60M-50M-40M-30M-20M-10M1Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EPS

Revenue Variation (%)

Income Variation (%)

Operating Income VariationNet Income Variation
062125188250312375438500Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue YoY Variation (%)

Income YoY Variation (%)

Operating Income YoY VariationNet Income YoY Variation
075150225300375450525600Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Price-to-Earning Ratio

P/E Ratio
-7-6-5-4-3-2-101Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
01M2M3M4M5M6M7M8MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
025M50M75M100M125M150M175M200MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
🏦 Balance Sheet
📈 Key Metrics